Sema Eryılmaz, MD

Sema Eryılmaz, MD is a specialist in Pediatric Endocrinology at Acibadem Altunizade Hospital in İstanbul, where she works within the Pediatrics unit. She has more than 33 years in medicine. Her subspecialty is Growth and Adolescence, and the areas of expertise listed on this profile are pediatric endocrinology, growth and development, and adolescent health.

Dr. Eryılmaz graduated from İstanbul University Faculty of Medicine in 1993. She completed her training in Child Health and Diseases at İstanbul University İstanbul Faculty of Medicine in 1998 and her training in Pediatric Endocrinology at the same faculty in 2009. From 1999 to 2000 she worked at İstanbul University İstanbul Faculty of Medicine Department of Child Health and Diseases, Division of Growth and Development and Pediatric Endocrinology. Between 2008 and 2009 she was at Kanlıca Mother and Child Health and Family Planning Training Center, and from 2009 to 2011 she completed compulsory service at Şanlıurfa Children’s Diseases Hospital. From 2011 to 2012 she practiced at Başkent University İstanbul Health Practice and Research Center Hospital before joining Acıbadem Healthcare Services in 2012. She is a member of the Pediatric Endocrinology and Diabetes Association, the İstanbul Turkish Medical Chamber, Türk Pediatri Kurumu, the İstanbul Faculty of Medicine, Department of Child Health and Diseases, Alumni Association, and the European Pediatric Endocrinology Association.

Clinical focus

Dr. Eryılmaz evaluates and manages endocrine conditions in children and adolescents. Growth and development is a central part of her work, and her profile lists adolescent health as a further area of expertise. Assessment in this field generally involves reviewing a child’s growth history and measurements, previous laboratory and imaging results, and any earlier treatment, before discussing whether further investigation or follow-up is appropriate.

Her published work, ten papers of which are listed on this page, reflects these interests. Several papers address growth hormone: the exon 3 deleted/full length growth hormone receptor polymorphism in relation to response to growth hormone therapy in growth hormone deficiency and Turner syndrome, the distribution of this polymorphism in the Turkish population, and the follow-up height of children with intrauterine growth retardation after growth hormone treatment was discontinued. Another group of papers concerns children born small for gestational age or preterm, covering ambulatory blood pressure monitoring, renal function, insulin resistance and body composition. She has also co-authored reports on pamidronate treatment in children with osteogenesis imperfecta, Beckwith Wiedemann syndrome, 22q11.2 syndrome, Hashimoto’s encephalopathy, and type 1 diabetes mellitus associated with autoimmune thyroid disease, celiac disease and Familial Mediterranean Fever.

How Dr. Eryılmaz works with international patients

Dr. Eryılmaz speaks Turkish and English, and interpreters can be arranged for families who need them. The Acibadem international patient team coordinates the collection of prior reports and imaging, arranges appointments and organizes the hospital visit. A first consultation typically covers the child’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the options. Video consultation is available for international patients, which may be used for an initial review of records or for follow-up where a physical examination is not required at that stage.